Pembrolizumab recommended as an adjuvant therapy for RCC across UKFeaturedThe Scottish Medical Consortium have recommended Pembrolizumab (Keytruda) as a monotherapy which is indicated for ...
Highlights from the ESMO Congress 2022FeaturedWe are delighted to share with you the report from The European Society of Medical Oncology (ESMO) congress 2022 ...